Briefly, patients who switched to Gla‐300 insulin had a mean (SD) age at index date was 64.2 ± 11.0 years, 42.5% were female, and 77.5% were included in the diabetes registry for more than 10 years. This evidence concerns the gene INS and diabetes mellitus.